trial summary · NCT06988319
Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study
Trial record from the TrialBase DB dataset, status RECRUITING, condition Chronic Pelvic Pain, sponsored by Oregon Health and Science University. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
The primary aim is to determine the feasibility of enrolling and 15 women with chronic pelvic pain (CPP) that have failed one conventional for CPP to obtain preliminary safety data on a single administration of a moderate dose of pharmaceutical grade psilocybin (25 mg) in combination with psychotherapy sessions (two pre-dose preparatory and three post-dose integration sessions).
Source record: https://clinicaltrials.gov/study/NCT06988319
Facts
| registry id | NCT06988319 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE1 |
| study type | INTERVENTIONAL |
| lead condition | Chronic Pelvic Pain |
| sponsor | Oregon Health and Science University |
| sponsor class | OTHER |
| enrollment | 15 |
| start date | 2026-11-01 |
| primary completion | 2027-12-31 |
| completion | 2027-12-31 |
| results posted | not reported |
Conditions
- Chronic Pelvic Pain
Interventions
- Psilocybin (Usona Institute)
Countries
- United States
Intervention types: DRUG
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.